APOE and Alzheimer disease: Meister et al. discovered that polylactide (PLA) nanoparticles containing the Aβ42 lowering drug flurbiprofen (as a potential therapy for Alzheimer’s disease (AD)) became quickly decorated with bioactive proteins, including apolipoprotein E, which actually aided the passage of the nanoparticle through the blood-brain-barrier [57].